The susceptibility to natural killer cell-mediated lysis of HLA class I-positive melanomas reflects the expression of insufficient amounts of different HLA class I alleles

European Journal of Immunology

Volumn 28, Issue 8, 1998, Pages 2384-2394

  Pende, Daniela ^a   Accame, Laura ^a   Pareti, Laura ^a   Mazzocchi, Arabella ^b   Moretta, Alessandro ^c   Parmiani, Giorgio ^b   Moretta, Lorenzo ^a,c  

^a CENTRO DI BIOTECNOLOGIE AVANZATE   (Italy)

^b NATIONAL CANCER INSTITUTE   (Italy)

^c UNIVERSITY OF GENOA   (Italy)

Author keywords

HLA class I; Killer inhibitory receptor; Melanoma cell; NK cell

Indexed keywords

HLA ANTIGEN CLASS 1;

ALLELE; ARTICLE; CONTROLLED STUDY; CYTOLYSIS; GENE EXPRESSION; GENE FREQUENCY; HISTOCOMPATIBILITY GENE; HUMAN; HUMAN CELL; MELANOMA; MELANOMA CELL; NATURAL KILLER CELL; PRIORITY JOURNAL;

ALLELES; ANTIBODIES, MONOCLONAL; AUTOIMMUNITY; B-LYMPHOCYTES; CELL LINE; CELL TRANSFORMATION, VIRAL; CYTOTOXICITY, IMMUNOLOGIC; DOWN-REGULATION; GENE EXPRESSION; GENES, MHC CLASS I; HERPESVIRUS 4, HUMAN; HUMANS; INTERFERON-GAMMA, RECOMBINANT; KILLER CELLS, NATURAL; MELANOMA; TUMOR CELLS, CULTURED;

EID: 0031879322     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1521-4141(199808)28:08<2384::AID-IMMU2384>3.0.CO;2-L     Document Type: Article

References (55)

1. Trinchieri, G., Biology of natural killer cells. Adv. Immunol. 1989. 47: 187-376.
2. Bancroft, G. J., The role of natural killer cells in innate resistance to infection. Curr. Opin. Immunol. 1993. 5: 503-510.
3. Moretta, L., Ciccone, E., Mingari, M. C., Biassoni, R. and Moretta, A., Human NK cells: origin, clonality, specificity and receptors. Adv. Immunol. 1994. 55: 341-380.
4. Ljunggren, H.-G. and Karre, K., In search of the ø"missing self". MHC molecules and NK cell recognition. lmmunol. Today 1990. 11: 237-244.
5. Liao, N. S., Bix, M., Zijstra, M., Jaenisch, R. and Raulet, D., MHC class I deficiency: susceptibility to natural killer (NK) cells and impaired NK activity. Science 1991. 253: 199-202.
6. Moretta, A., Bottino, C., Vitale, M., Pende, D., Biassoni, R., Mingari, M. C. and Moretta, L., Receptors for HLA-class I-molecules in human Natural Killer cells. Annu. Rev. Immunol. 1996. 14: 619-648.
7. Colonna, M. and Samaridis, J., Cloning of immunoglobulin-superfamily members associated with HLA-C and HLA-B recognition by human natural killer cells. Science 1995. 268: 405-408.
8. Wagtmann, N., Biassoni, R., Cantoni, C., Verdiani, S., Malnati, M., Vitale, M., Bottino, C., Moretta, L., Moretta, A. and Long, E. O., Molecular clones of the p58 Natural Killer cell receptor reveal Ig-related molecules with diversity in both the Extra- and Intracellular domains. Immunity 1995. 2: 439-449.
9. D'Andrea, A., Chang, C., Franz-Bacon, K., McClanahan, T., Phillips, J.-H. and Lanier, L. L., Molecular cloning of NKB1. A natural killer cell receptor for HLA-B allo-types. J. Immunol. 1995. 155: 2306-2310.
10. Moretta, A., Vitale, M., Bottino, C., Orengo, A. M., Morelli, L., Augugliaro, R., Barbaresi, M., Ciccone, E. and Moretta, L., P58 molecules as putative receptors for MHC class I molecules in human Natural Killer (NK) cells. Anti-p58 antibodies reconstitute lysis of MHC class I-protected cells in NK clones displaying different specificities. J. Exp. Med. 1993. 178: 597-604.
11. Colonna, M., Spies, T., Strominger, J. L., Ciccone, E., Moretta, A., Moretta, L., Pende, D. and Viale, O., Alloantigen recognition by human Natural Killer cells is associated with HLA-C or a closely linked gene. Proc. Natl. Acad. Sci. USA 1992. 89: 7983-7985.
12. Biassoni, R., Falco, M., Cambiaggi, A., Costa, P., Verdiani, S., Pende, D., Conte, R., Di Donate, C., Parham, P. and Moretta, L., Amino acid substitutions can influence the Natural Killer (NK)-mediated recognition of HLA-C molecules. Role of serine-77 and lysine-80 in the target cell protection from lysis mediated by "Group 2" or "Group 1" NK clones. J. Exp. Med. 1995. 182: 605-609.
13. Litwin, V., Gumperz, J. E., Parham, P., Phillips, J. H. and Lanier, L. L., NKB1: a Natural Killer cell receptor involved in the recognition of polymorphic HLA-B molecules. J. Exp. Med. 1994. 180: 537-543.
14. Vitale, M., Sivori, S., Pende, D., Augugliaro, R., Di Donato, C., Amoroso, A., Malnati, M., Bottino, C., Moretta, L. and Moretta, A., Physical and functional independency of p70 and p58 cell receptors for HLA-class I. Their role in the definition of different groups of alloreactive NK cell clones. Proc. Natl. Acad. Sd. USA 1996. 93: 1453-1457.
15. Pende, D., Biassoni, R., Cantoni, C., Verdiani, S., Falco, M., Di Donato, C., Accame, L., Bottino, C., Moretta, A. and Moretta, L., The Natural Killer cell receptor specific for HLA-A allotypes: a novel member of the p58/p70 family of inhibitory receptors that is characterized by three immunoglobulin-like domains and is expressed as a 140 kD disulphide-linked dimer. J. Exp. Med. 1996. 184: 505-518.
16. Dohring, C., Scheidegger, D., Samaridis, J., Cella, M. and Colonna, M., A human killer inhibitory receptor specific for HLA-A. J. Immunol. 1996. 156: 3098-3101.
17. Moretta, A., Vitale, M., Sivori, S., Bottino, C., Morelli, L., Augugliaro, R., Barbaresi, M., Pende, D., Ciccone, E., Lopez-Bote, M. and Moretta, L., Human Natural Killer cell receptors for HLA-class I molecules. Evidence that the Kp43 (CD94) molecule functions as receptor for HLA-B alleles. J. Exp. Med. 1994. 180: 545-555.
18. Chang, C., Rodriguez, A., Carretero, M., López-Botet, M., Phillips, J. H. and Lanier, L. L., Molecular characterization of human CD94: a type II membrane glycoprotein related to the C-type lectin superfamily. Eur. J. Immunol. 1995. 25: 2433-2437.
19. Sivori, S., Vitale, M., Bottino, C., Marcenaro, E., Sanseverino, L., Parolini, S., Moretta, L. and Moretta, L., CD94 functions as a natural killer cell inhibitory receptor for different HLA-CLASS-I alleles. Identification of the inhibitory form of CD94 by the use of novel monoclonal antibodies. Eur. J. Immunol. 1996. 26: 2487-2492.
20. Phillips, J. H., Chang, C., Mattson, J., Gumperz, J. E., Parham, P. and Lanier, L. L., CD94 and a novel associated protein (94AP) form a NK cell receptor involved in the recognition of HLA-A, HLA-B, and HLA-C allotypes. Immunity 1996. 5: 163-172.
21. Carretero, M., Cantoni, C., Bellón, T., Bottino, C., Biassoni, R., Rodriguez, A., Pérez-Villar, J. J., Moretta, L., Moretta, A. and López-Botet, M., The CD94 and NKG2-A C-type lectins covalently assemble to form a NK cell inhibitory receptor for HLA class I molecules. Eur. J. Immunol. 1997. 27: 563-567.
22. Brooks, A. G., Posch, P. E., Scorzelli, C. J., Borrego, F. and Coligan, J. E., NKG2A complexed with CD94 defines a novel inhibitory natural killer cell receptor. J. Exp. Med. 1997. 185: 795-800.
23. Braud, W. M., Allan, D. S. J., O'Callaghan, C. A., Soderstrom, K., D'Andrea, A., Ogg, G. S., Lazetic, S., Young, N. T., Bell, J. I., Phillips, J. H., Lanier, L. L. and McMichael, A. J., HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C. Nature 1998. 391: 795-799.
24. Borrego, F., Ulbrecht, M., Weiss, E. H., Coligan, J. E. and Brooks, A. G., Recognition of human histocompatibility leukocyte antigen (HLA)-E complexed with HLA-class I signal sequence derived peptides by CD94/NKG2 confers protection from Natural Killer cell-mediated lysis. J. Exp. Med. 1998. 187: 813-818.
25. Lee, N., Llano, M., Carretero, M., Ishitani, A., Navarro, F., López-Botet, M. and Geraghty, D., HLA-E is a major ligand for the natural killer inhibitory receptor CD94/ NKG2A. Proc. Natl. Acad. Sci. USA 1998. 95: 5199-5204.
26. Braud, V., Jones, E. Y. and McMichael, A., The human major histocompatibility complex class lb molecule. HLA-E binds signal sequence-derived peptides with primary anchor residues at position 2 and 9. Eur. J. Immunol. 1997. 27: 1164-1169.
27. Braud, V. M., Allan, D. S. J., Wilson, D. and McMichael, A. J., TAP- and tapasin-dependent HLA-E surface expression correlates with the binding of an MHC class I leader peptide. Curr. Biol. 1998. 8: 1-10.
28. Long, E. O., Signal sequences stop killer cells. Nature 1998. 391: 740-743.
29. Lanier, L. L., Natural Killer Cells: from no receptors to too many. Immunity 1997. 6: 371-378.
30. Moretta, A., Biassoni, R., Bottino, C., Pende, D., Vitale, M., Poggi, A., Mingari, M. C. and Moretta, L., Major Histocompatibility complex Class I specific receptors on human Natural Killer and T lymphocytes. Immunol. Rev. 1997. 155: 105-117.
31. Anichini, A., Mortarini, R., Supino, R. and Parmiani, G., Human melanoma cells with high susceptibility to cell-mediated lysis can be identified on the basis of ICAM-1 phenotype, VLA profile and invasive ability. Int. J. Cancer 1990. 46: 508-515.
32. Porgador, A., Mandelboim, O., Restifo, N. P. and Strominger, J. L., Natural Killer cell lines kill autologous β2-microglobulin-deficient melanoma cells: implications for cancer immunotherapy. Proc. Natl. Acad. Sci. USA 1997. 94: 13140-13145.
33. Rosenberg, S. A., Kawakami, Y., Robbins, P. F. and Wang, R., Identification of the genes encoding cancer antigens: implications for cancer immunotherapy. Adv. Cancer Res. 1996. 70: 145-177.
34. Boon, T. and van der Bruggen, P., Human tumor antigens recognized by T lymphocytes. J. Exp. Med. 1996. 183: 725-729.
35. Smith, M. E. F., Bodmer, S. G., Kelly, A. P., Trowsdale, J., Kirkland, S. C. and Bodmer, W. F., Variation in HLA expression on tumors: an escape from immune response. Cold Spring Harb. Symp. Quant. Biol. 1989. 54: 581-586.
36. Lehmann, F., Marchand, M., Hainaut, P., Pouillart, P., Sastre, X., Ikeda, H., Boon, T. and Coulie, P. G., Differences in the antigens recognized by cytolytic T cells on two successive metastases of a melanoma patient are consistent with immune selection. Eur. J. Immunol. 1995. 25: 340-347.
37. Ikeda, H., Lethé, B., Lehmann, F., Van Baren, N., Baurain, J. F., De Smet, C., Chambost, H., Vitale, M., Moretta, A., Boon, T. and Coulie, P. G., Characterization of an antigen that is recognized on a melanoma showing partial loss by CTL expressing an NK inhibitory receptor. Immunity 1997. 6: 199-208.
38. Jager, E., Ringhoffer, M., Altmannsberger, M., Arand, M., Karbach, J., Jager, D., Oesch, F. and Knuth, A., Immunoselection in vivo: independent loss of MHC class I and melanocyte differentiation antigen expression in metastatic melanoma. Int. J. Cancer 1997. 71: 142-147.
39. Natali, P. G., Nicotra, M. R., Bigotti, A., Venture, I., Marcenaro, L., Giacomini, P. and Russo, C., Selective changes in expression of HLA class I polymorphic determinants in human solid tumors. Proc. Natl. Acad. Sci. USA 1989. 86: 6719-6723.
40. Marincola, F. M., Shamamian, P., Alexander, R. B., Gnarra, J. R., Turetskaya, R. L., Nedospasov, S. A., Simonis, T. B., Taubenberger, J. K., Yannelli, J., Mixon, A., Restifo, N. P., Herlyn, M. and Rosenberg, S. A., Loss of HLA haplotype and B locus down-regulation in melanoma cell lines. J. Immunol. 1994. 153: 1225-1237.
41. Versteeg, R., Krüse-Wolters, K. M., Plomp, A. C., van Leeuwen, A., Stam, N. J., Ploegh, H. L., Ruiter, D. J. and Schrier, P. I., Suppression of class I human histocompatibility leukocyte antigen by c-myc is locus specific. J. Exp. Med. 1989. 170: 621-635.
42. Rivoltini, L., Baracchini, K. C., Viggiano, V., Kawakami, Y., Smith, A., Mixon, A., Restifo, N. P., Topalian, S. L., Simonis, T. B. and Rosenberg, S. A., Quantitative correlation between HLA class I allele expression and recognition of melanoma cells by antigen-specific cytotoxic T lymphocytes. Cancer Res. 1995. 55: 3149-3157.
43. Ferrone, S. and Marincola, F. M., Loss of HLA-class I antigens by melanoma cells: molecular mechanisms, functional significance and clinical relevance. Immunol. Today 1995. 16: 487-494.
44. Garrido, F., Ruiz-Cabello, F., Cabrera, R., Pérez-Villar, J. J., López-Botet, M., Duggan-Keen, M. and Stern, P. L., Implications for immunosurveillance of altered HLA-class I phenotypes in human tumours. Immunol. Today 1997. 18: 89-95.
45. 2m gene. J. Clin. Invest. 1991. 88: 282-289.
46. Maio, M. and Parmiani, G., Melanoma immunotherapy: new dreams or solid hopes? Immunol. Today 1996. 17: 405-407.
47. Valitutti, S., Muller, S., Dessing, M. and Lanzavecchia, A., Different responses are elicited in cytotoxic T lymphocytes by different levels of T cell receptor occupancy. J. Exp. Med. 1996. 183: 1917-1921.
48. Labarriere, N., Diez, E., Pandolfino, M. C., Viret, C., Guilloux, Y., Le Guiner, S., Fonteneau, J. F., Dreno, B. and Jotereau, F., Optimal T cell activation by melanoma cells depends on a minimal level of antigen transcription. J. Immunol. 1997. 158: 1238-1245.
49. Mazzocchi, A., Storkus, W. J., Traversari, C., Tarsini, P., Maeurer, M. J., Rivoltini, L., Vegetti, C., Belli, F., Anichini, A., Parmiani, G. and Castelli, C., Multiple melanoma-associated epitopes recognized by HLA-A3-restricted CTLs and shared by melanomas but not melanocytes. J. Immunol. 1996. 157: 3030-3038.
50. 17-25) peptide in HLA-A3.1 melanoma patients. Eur. J. Immunol. 1998. 28: 1143-1154.
51. Marsh, S. G. E., Krausa, P. and Bodmer, J. G., A preliminary analysis of the 11th international histocompatibility workshop: monoclonal antibodies. Tissue Antigens 1990. 36: 180-186.
52. Ciccone, E., Pende, D., Viale, O., Di Donato, C., Orengo, A. M., Biassoni, R., Verdiani, S., Amoroso, A., Moretta, A. and Moretta, L., Involvement of HLA class I alleles in NK cell specific functions: expression of HLA-Cw3 confers selective protection from lysis by alloreactive NK clones displaying a defined specificity (specific ity 2). J. Exp. Med. 1992. 176: 963-971.
53. Ciccone, E., Pende, D., Vitale, M., Nanni, L., Di Donato, C., Bottino, C., Morelli, L., Viale, O., Amoroso, A., Moretta, A. and Moretta, L., Self class I molecules protect normal cells from lysis mediated by autologous Natural Killer cells. Eur. J. Immunol. 1994. 24: 1003-1006.
54. Moretta, A., Tambussi, G., Bottino, C., Tripodi, G., Merli, A., Ciccone, E., Pantaleo, G. and Moretta, L., A novel surface antigen expressed by a subset of human CD3-CD16+ Natural Killer cells. Role in cell activation and regulation of cytolytic function. J. Exp. Med. 1990. 171: 695-714.
55. Moretta, A., Bottino, C., Pende, D., Tripodi, G., Tambussi, G., Viale, O., Orengo, A., Barbaresi, M., Merli, A., Ciccone, E. and Moretta, L., Identification of four subsets of human CD3-CD16+ NK cells by the expression of clonally distributed functional surface molecules. Correlation between subset assignment of NK clones and ability to mediate specific alloantigen recognition. J. Exp. Med. 1990. 172: 1589-1598.